Data reflects in-vivo clinical assessments of the active components (used in the formula), commissioned by their developers and conducted according to their protocols.

METHODOLOGY: Instrumental assessment (3D Profilometry / Corneometry) + expert visual scoring.

SUBJECT: Independent cohorts (n=17 to n=29 volunteers) • 28-day protocol (Evaluation: Day 0 → Day 28).

VECTOR 1 [Volumetric Expansion]: Average +15.1% increase in visible lip volume (Active component: Volumetric Biomimetic Peptide).

VECTOR 2 [Vertical Relief Neutralization]: Average −19% reduction in the structural volume of vertical perioral lines (Active component: Biomimetic Signal Matrix).

VECTOR 3 [Corneometric Retention]: Average +50.6% increase in sustained surface retention (Active component: Lipid-Encapsulated HA Matrix).

Clinical Declaration: The data isolates the capacity of the incorporated active components. Individual surface architecture determines the final visual outcome.